Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

J. Compston; D. M. Reid; J. Boisdron; M. -L. Brandi; N. Burlet; D. Cahall; P. D. Delmas; W. Dere; J. -P. Devogelaer; L. A. Fitzpatrick; B. Flamion; N. Goel; S. Korte; A. Laslop; B. Mitlak; S. Ormarsdottir; J. Ringe; R. Rizzoli; Y. Tsouderos; T. Van Staa; J. -Y. Reginster

doi:10.1007/s00198-008-0670-7

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

J. Compston, D. M. Reid, J. Boisdron, M. -L. Brandi, N. Burlet, D. Cahall, P. D. Delmas, W. Dere, J. -P. Devogelaer, L. A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van StaaJ. -Y. Reginster

Applied Medicine

Research output: Contribution to journal › Article

22 Citations (Scopus)

Original language	English
Pages (from-to)	1247-1250
Number of pages	4
Journal	Osteoporosis International
Volume	19
Issue number	9
Early online date	5 Jul 2008
DOIs	https://doi.org/10.1007/s00198-008-0670-7
Publication status	Published - Sept 2008

Keywords

bone mineral density
bridging study
glucocorticoid-induced osteoporosis
men
phase III studies
postmenopausal women
corticosteroid-induced osteoperosis
oral corticosteroids
fracture risk
bone loss
metaanalysis
risedronate
alendronate
therapy

Access to Document

10.1007/s00198-008-0670-7

Cite this

Compston, J., Reid, D. M., Boisdron, J., Brandi, M. .-L., Burlet, N., Cahall, D., Delmas, P. D., Dere, W., Devogelaer, J. .-P., Fitzpatrick, L. A., Flamion, B., Goel, N., Korte, S., Laslop, A., Mitlak, B., Ormarsdottir, S., Ringe, J., Rizzoli, R., Tsouderos, Y., ... Reginster, J. .-Y. (2008). Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science. Osteoporosis International, 19(9), 1247-1250. https://doi.org/10.1007/s00198-008-0670-7

Compston, J, Reid, DM, Boisdron, J, Brandi, M-L, Burlet, N, Cahall, D, Delmas, PD, Dere, W, Devogelaer, J-P, Fitzpatrick, LA, Flamion, B, Goel, N, Korte, S, Laslop, A, Mitlak, B, Ormarsdottir, S, Ringe, J, Rizzoli, R, Tsouderos, Y, Van Staa, T & Reginster, J-Y 2008, 'Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science', Osteoporosis International, vol. 19, no. 9, pp. 1247-1250. https://doi.org/10.1007/s00198-008-0670-7

@article{664f17a95de74bc68c18a1062a853367,

title = "Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science",

keywords = "bone mineral density, bridging study, glucocorticoid-induced osteoporosis, men, phase III studies, postmenopausal women, corticosteroid-induced osteoperosis, oral corticosteroids, fracture risk, bone loss, metaanalysis, risedronate, alendronate, therapy",

author = "J. Compston and Reid, {D. M.} and J. Boisdron and Brandi, {M. -L.} and N. Burlet and D. Cahall and Delmas, {P. D.} and W. Dere and Devogelaer, {J. -P.} and Fitzpatrick, {L. A.} and B. Flamion and N. Goel and S. Korte and A. Laslop and B. Mitlak and S. Ormarsdottir and J. Ringe and R. Rizzoli and Y. Tsouderos and {Van Staa}, T. and Reginster, {J. -Y.}",

year = "2008",

month = sep,

doi = "10.1007/s00198-008-0670-7",

language = "English",

volume = "19",

pages = "1247--1250",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "SPRINGER-VERLAG LONDON LTD",

number = "9",

}

TY - JOUR

T1 - Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis

T2 - an update from the Group for the Respect of Ethics and Excellence in Science

AU - Compston, J.

AU - Reid, D. M.

AU - Boisdron, J.

AU - Brandi, M. -L.

AU - Burlet, N.

AU - Cahall, D.

AU - Delmas, P. D.

AU - Dere, W.

AU - Devogelaer, J. -P.

AU - Fitzpatrick, L. A.

AU - Flamion, B.

AU - Goel, N.

AU - Korte, S.

AU - Laslop, A.

AU - Mitlak, B.

AU - Ormarsdottir, S.

AU - Ringe, J.

AU - Rizzoli, R.

AU - Tsouderos, Y.

AU - Van Staa, T.

AU - Reginster, J. -Y.

PY - 2008/9

Y1 - 2008/9

KW - bone mineral density

KW - bridging study

KW - glucocorticoid-induced osteoporosis

KW - men

KW - phase III studies

KW - postmenopausal women

KW - corticosteroid-induced osteoperosis

KW - oral corticosteroids

KW - fracture risk

KW - bone loss

KW - metaanalysis

KW - risedronate

KW - alendronate

KW - therapy

U2 - 10.1007/s00198-008-0670-7

DO - 10.1007/s00198-008-0670-7

M3 - Article

SN - 0937-941X

VL - 19

SP - 1247

EP - 1250

JO - Osteoporosis International

JF - Osteoporosis International

IS - 9

ER -